AI assistant
Sending…
RxSight, Inc. — Director's Dealing 2025
Jun 4, 2025
33077_dirs_2025-06-03_b485f0b9-29bd-47fa-9aa6-f2edb54b32ce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RxSight, Inc. (RXST)
CIK: 0001111485
Period of Report: 2025-06-02
Reporting Person: Weinberg Eric (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-02 | Common Stock | M | 188002 | $3.93 | Acquired | 195351 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-06-02 | Stock Option (right to buy) | $3.93 | M | 188002 | Disposed | 2025-07-29 | Common Stock (188002) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 299978 | Indirect |
| Common Stock | 925 | Indirect |
Footnotes
F1: Includes 1,121 shares of Common Stock acquired April 30, 2024 under the Issuer's 2021 Employee Stock Purchase Plan.
F2: Shares held by the EJW Living Trust, for which the Reporting Person serves as trustee.
F3: Form 3 filed July 29, 2021 incorrectly reflected 187,998 shares.
More from RxSight, Inc.
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 25
Regulatory Filings
2026
Feb 25
Major Shareholding Notification
2026
Feb 3
Director's Dealing
2026
Jan 30